Additionally, the potential for CBX3 to influence prostate cancer growth by modulating the PI3K/AKT pathway has been suggested [16]; however, the significance of the interplay of CBX3 with the PI3K/AKT pathway in ccRCC is unclear. This evidence concerns the gene CBX3 and nonpapillary renal cell carcinoma.